Business / Finance

RSS

Spectros reports 51% increase in year-to-date Oximeter sales revenue for 2011

Spectros Corporation announced today that 2011 year-to-date sales revenue rose 51% over the similar period in 2010.

30 Jul 2011

Lupin, Lilly partner to promote and distribute Huminsulin products in India and Nepal

Eli Lilly India and Lupin Limited today announced they have entered into a strategic collaboration to promote and distribute Lilly's Huminsulin range of products, including Huminsulin R, Huminsulin NPH, Huminsulin 50/50, Huminsulin 30/70 and Humapen Ergo II.

30 Jul 2011

First Surgical announces quarterly cash dividend of $0.0275 per share

First Surgical Partners Inc., which provides non-threatening surgeries through its two ambulatory surgery centers and a general acute care hospital, is pleased to announce today that its Board of Directors declared a quarterly cash dividend of $0.0275 per share on its shares of common stock that will be paid on August 12, 2011 to stockholders of record on August 11, 2011.

30 Jul 2011

NORCAL enters definitive merger agreement to acquire Medicus

Today, NORCAL Mutual Insurance Company of San Francisco, CA announced that it has entered into a definitive merger agreement for the acquisition of Medicus Insurance Holdings, Inc. of Austin, TX and its wholly-owned subsidiary, Medicus Insurance Company.

30 Jul 2011

Sorin Group second quarter revenues increase 0.6% to €191.9 million

Sorin Group: Consolidated results for second quarter 2011: Revenues of €191.9 million, a 0.6% increase over the same period last year.

30 Jul 2011

UK bioindustry raises $250m in financing during second quarter 2011

The UK bioindustry has raised over $250m in financing during the second quarter of 2011, the largest amount raised in any quarter for one year, and the second largest amount raised in any of the last 20 quarters.

30 Jul 2011

Standard Register reports net loss of $0.9 million for second quarter 2011

Standard Register today announced its financial results for the second quarter.

30 Jul 2011

EGT transfers clinical grade lentiviral vector to MSKCC

Errant Gene Therapeutics, LLC, a pioneering boutique drug development firm specializing in Rare Diseases, announced the transfer of its clinical grade lentiviral vector, TNS 9.55.3, to Memorial Sloan Kettering Cancer Center.

29 Jul 2011

Anthera reports increase in second quarter total operating expenses to $22.7 million

Anthera Pharmaceuticals, Inc., today announced financial results and business highlights for the quarter ended June 30, 2011.

29 Jul 2011

Amgen reports 8% increase in second quarter total product sales to $3,893 million

Amgen reported total revenue increased 4 percent during the second quarter of 2011 to $3,959 million versus $3,804 million in the second quarter of 2010. Total product sales increased 8 percent in the second quarter of 2011 to $3,893 million versus $3,613 million in the second quarter of 2010. The increase in total revenue in the second quarter of 2011 included a decline in other revenue due to certain milestone payments earned in the second quarter of 2010.

29 Jul 2011

Merck reports worldwide sales of $12.2 billion for second quarter 2011

Merck, known as MSD outside the United States and Canada, today announced financial results for the second quarter of 2011.

29 Jul 2011

Span-America announces quarterly dividend of $0.11 per share

Span-America Medical Systems, Inc. announced today that the Board of Directors declared a regular quarterly dividend of $0.11 per share.

29 Jul 2011

LifePoint Hospitals second quarter revenues increase 11.0% to $877.6 million

LifePoint Hospitals, Inc. today announced results for the second quarter and six months ended June 30, 2011.

29 Jul 2011

HMS second quarter revenue increases 26% to $89.3 million

HMS today announced its financial results for the second quarter of 2011.

29 Jul 2011

Amerigroup second quarter total revenues increase 6.3% to $1.53 billion

Amerigroup Corporation today announced that net income for the second quarter of 2011 was $44.3 million, or $0.83 per diluted share, versus net income of $67.2 million, or $1.31 per diluted share, for the second quarter of 2010 and compared to $70.5 million, or $1.37 per diluted share, for the first quarter of 2011.

29 Jul 2011

Aon second quarter total revenue increases 48% to $2.8 billion

Aon Corporation today reported results for the second quarter ended June 30, 2011.

29 Jul 2011

Magellan reports second quarter net revenue of $698.3 million

Magellan Health Services Inc. today reported financial results for the second quarter of 2011, as summarized below. For the quarter ended June 30, 2011, the company reported net revenue of $698.3 million, segment profit of $75.9 million, and net income of $34.2 million or $1.07 per diluted common share.

29 Jul 2011